Literature DB >> 26831056

Relationship of hepatic steatosis severity and coronary artery disease characteristics assessed by coronary CT angiography.

Nobuo Tomizawa1, Shinichi Inoh2, Takeshi Nojo2, Sunao Nakamura3.   

Abstract

The objective of this study was to investigate the relationship between the severity of hepatic steatosis and coronary artery disease characteristics assessed by coronary computed tomography (CT) angiography. This retrospective analysis consisted of 2028 patients. Hepatic steatosis was evaluated by liver attenuation on unenhanced CT and the patients were divided into four groups (≥60 HU, 54-59 HU, 43-53 HU, ≤42 HU). Coronary calcification was calculated using the Agatston method. Obstructive disease was defined as ≥50 % stenosis assessed by CT. A high-risk plaque was defined by a remodeling index >1.1 and low attenuation (<30 HU). Patients with a segment involvement score >4 were determined to have extensive disease. Logistic regression analysis was performed to study multivariate associations. Severity of hepatic steatosis was associated with coronary calcification (p = 0.02), obstructive disease (p < 0.0001), presence of a high-risk plaque (p = 0.0001) and extensive disease (p = 0.001) in the univariate analysis. However, the relationships were attenuated in the multivariate analysis with the exception of obstructive disease (p = 0.04). Liver attenuation of <54 HU was significantly associated with obstructive coronary artery disease independent of conventional risk factors such as age, sex, diabetes mellitus, hypertension, dyslipidemia and smoking (hepatic attenuation 43-53 HU, odds ratio 1.52, 95 % confidence interval 1.11-2.10, p = 0.01; ≤42 HU, odds ratio 1.65, 95 % confidence interval 1.10-2.45, p = 0.02). Although conventional risk factors were stronger predictors of coronary calcification and plaque formation, the severity of hepatic steatosis remained an independent risk factor for obstructive coronary artery disease. Coronary CT angiography may play a potential role in risk stratification for patients with hepatic steatosis.

Entities:  

Keywords:  Computed tomography angiography; Coronary artery disease; Hepatic steatosis

Mesh:

Substances:

Year:  2016        PMID: 26831056     DOI: 10.1007/s10554-016-0847-7

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  32 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Executive summary: Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

3.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

4.  Difference of coronary artery disease severity, extent and plaque characteristics between patients with hypertension, diabetes mellitus or dyslipidemia.

Authors:  Nobuo Tomizawa; Takeshi Nojo; Shinichi Inoh; Sunao Nakamura
Journal:  Int J Cardiovasc Imaging       Date:  2014-09-28       Impact factor: 2.357

5.  Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Gabriel Wai-Kwok Yip; Angeline Oi-Shan Lo; Jenny Limquiaco; Winnie Chiu-Wing Chu; Angel Mei-Ling Chim; Cheuk-Man Yu; Jun Yu; Francis Ka-Leung Chan; Joseph Jao-Yiu Sung; Henry Lik-Yuen Chan
Journal:  Gut       Date:  2011-05-20       Impact factor: 23.059

Review 6.  A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?

Authors:  Ebenezer T Oni; Arthur S Agatston; Michael J Blaha; Jonathan Fialkow; Ricardo Cury; Andrei Sposito; Raimund Erbel; Ron Blankstein; Ted Feldman; Mouaz H Al-Mallah; Raul D Santos; Matthew J Budoff; Khurram Nasir
Journal:  Atherosclerosis       Date:  2013-08-09       Impact factor: 5.162

7.  Presence of coronary plaques in patients with nonalcoholic fatty liver disease.

Authors:  Nimer Assy; Agness Djibre; Raymond Farah; Maria Grosovski; Alon Marmor
Journal:  Radiology       Date:  2010-02       Impact factor: 11.105

8.  Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT).

Authors:  Satoshi Akabame; Masahide Hamaguchi; Ki-Ichiro Tomiyasu; Muhei Tanaka; Yoshiko Kobayashi-Takenaka; Koji Nakano; Yohei Oda; Toshikazu Yoshikawa
Journal:  Circ J       Date:  2008-04       Impact factor: 2.993

9.  Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.

Authors:  Sudha B Biddinger; Antonio Hernandez-Ono; Christian Rask-Madsen; Joel T Haas; José O Alemán; Ryo Suzuki; Erez F Scapa; Chhavi Agarwal; Martin C Carey; Gregory Stephanopoulos; David E Cohen; George L King; Henry N Ginsberg; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

10.  Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals.

Authors:  Rajiv Chhabra; James H O'Keefe; Harshal Patil; Evan O'Keefe; Randall C Thompson; Shaya Ansari; Kevin F Kennedy; Linda W Lee; John H Helzberg
Journal:  Mayo Clin Proc       Date:  2013-10-16       Impact factor: 7.616

View more
  4 in total

1.  The correlation between hepatic fat fraction evaluated by dual-energy computed tomography and high-risk coronary plaques in patients with non-alcoholic fatty liver disease.

Authors:  Rui Zhan; Rongxing Qi; Sheng Huang; Yang Lu; Xiaoyu Wang; Jiashen Jiang; Xiwu Ruan; Anyi Song
Journal:  Jpn J Radiol       Date:  2021-04-05       Impact factor: 2.374

2.  Hepatosteatosis and Atherosclerotic Plaque at Coronary CT Angiography.

Authors:  Jessica Carter; Thomas D Heseltine; Mohammed N Meah; Evangelos Tzolos; Jacek Kwiecinski; Mhairi Doris; Priscilla McElhinney; Alastair J Moss; Philip D Adamson; Amanda Hunter; Shirjel Alam; Anoop S V Shah; Tania Pawade; Chengjia Wang; Jonathan R Weir-McCall; Giles Roditi; Edwin J R van Beek; Edward D Nicol; Leslee J Shaw; Daniel S Berman; Piotr J Slomka; Nicholas L Mills; Marc R Dweck; David E Newby; Scott W Murray; Damini Dey; Michelle C Williams
Journal:  Radiol Cardiothorac Imaging       Date:  2022-04-28

3.  Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT.

Authors:  Tomas Vita; David J Murphy; Michael T Osborne; Navkaranbir S Bajaj; Abhishek Keraliya; Sophia Jacob; Angel Joel Diaz Martinez; Ariana Nodoushani; Paco Bravo; Jon Hainer; Courtney F Bibbo; Michael L Steigner; Viviany R Taqueti; Hicham Skali; Ron Blankstein; Marcelo F Di Carli; Sharmila Dorbala
Journal:  Radiology       Date:  2019-03-05       Impact factor: 29.146

4.  Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.

Authors:  Anders Gummesson; Ulf Strömberg; Caroline Schmidt; Joel Kullberg; Oskar Angerås; Stefan Lindgren; Ola Hjelmgren; Kjell Torén; Annika Rosengren; Björn Fagerberg; John Brandberg; Göran Bergström
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.